AGA Medical Reaches Settlement With Justice Dept. Over Bribes In China
This article was originally published in PharmAsia News
Executive Summary
AGA Medical, a private firm that makes patent foramen ovale closure devices, agreed June 3 to immediately pay a $2 million criminal penalty under the Foreign Corrupt Practices Act (FCPA) and enter into a deferred prosecution agreement with the U.S. Department of Justice in connection with payments the company made to doctors in China
You may also be interested in...
Anti-Corruption Regs In China Should Be Warning Sign For Companies
The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, according to Australia medical device lobbyist Anne Trimmer
Anti-Corruption Regs In China Should Be Warning Sign For Companies
The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, according to Australia medical device lobbyist Anne Trimmer